Product Information
EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $1.1249 per EA under NDC 33342013807. Its NADAC has been published 257 times since Nov 3, 2021.
FDA first approved this application on Sep 13, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB
Efavirenz, Emtricitabine and Tenofovir Disoproxil FumarateStrength
600; 200; 300 mg/1; mg/1; mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342013807
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATEApproval Type
Generic (ANDA)
FDA Application
ANDA204287FDA Approved
9/13/2021
TE Code
AB
On Market Since
9/13/2021
Pharmacological Classes
Price Statistics
The NADAC for EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB has been published 257 times since Nov 3, 2021, and over the history we have for it it has declined 84.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.1249 per EA |
|---|---|
| All-time high | $7.0703 (Dec 15, 2021) |
| All-time low | $1.1249 (Sep 23, 2026) |
| 52-week high | $1.4461 |
| 52-week low | $1.1249 |
| Median price | $1.6592 |
| Average price | $2.8057 |
| Largest weekly change | -74.7% (Aug 23, 2023) |
| Weeks tracked | 257 |
| Tracking since | Nov 3, 2021 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Macleods Pharmaceuticals Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB, manufactured by Macleods Pharmaceuticals Limited, is $1.1249 per EA (NDC 33342013807), effective Sep 30, 2026.
How has the price of EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB changed over time?
Over the history we have for it, the NADAC for EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB has declined 84.1%. It has been tracked across 257 weekly CMS publications since Nov 3, 2021.
What are the highest and lowest recorded NADAC prices for EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB?
Since Nov 3, 2021, the NADAC for EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB has ranged from a low of $1.1249 (Sep 23, 2026) to a high of $7.0703 (Dec 15, 2021), with a median of $1.6592 per EA.
Are there cheaper alternatives to EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB?
EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB (NDC 33342013807) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.